Patientenforschung
Anmelden
Alle Studien
RekrutierungNAINTERVENTIONELL

French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis

This study is investigating why people with Amyotrophic Lateral Sclerosis (ALS), also known as Motor Neuron Disease, often lose weight. Weight loss can be a significant challenge for people with ALS, and understanding its causes could lead to better ways to manage the condition. Researchers will gather information from ALS patients in France and Germany. They will collect blood samples to look for biological clues and ask participants to complete questionnaires about their health. By identifying what causes weight loss, the study aims to improve the care and quality of life for people living with ALS. This research does not involve new medicines, but rather helps us understand the disease better.

Auf einen Blick

Status
Rekrutierung
Phase
NA
Sponsor
University Hospital, Limoges
Einschreibeziel
1,000
Starten
17 Sep 2024
Geschätzte Fertigstellung
30 Sep 2029
Amyotrophe Lateralsklerose

Worum geht es in dieser Studie?

This study is focused on Amyotrophic Lateral Sclerosis (ALS), which is also known as Motor Neuron Disease. It's a condition that affects the nerves in the brain and spinal cord, leading to muscle weakness. A common problem for people with ALS is losing weight, and this can happen both when first diagnosed and as the disease progresses.

While we know weight loss is common, doctors don't fully understand why it happens in ALS. This study aims to find those answers. By understanding the underlying reasons for weight loss, researchers hope to develop better strategies to help people with ALS maintain their weight. This could potentially improve their overall health, how they feel day-to-day, and even how long they live.

To do this, a team of doctors and researchers from France and Germany are working together. They are creating a large group of people with ALS (a cohort) who will take part. They will carefully study these individuals to find specific signals or 'markers' in their bodies that are linked to weight loss. This will involve collecting blood samples for detailed analysis and asking participants to fill out questionnaires about their health and lifestyle.

Wichtige Erkenntnisse

  • This study explores why people with ALS lose weight.
  • It aims to find biological reasons for weight loss to improve patient care.
  • Participation involves questionnaires and blood samples, no new drugs.
  • The study includes patients from France and Germany.
  • Findings could help develop better ways to manage ALS and improve quality of life.

Wer könnte berechtigt sein?

To join this study, you need to be an adult over 18 years old and have been recently diagnosed with ALS, according to specific medical guidelines. You must also be receiving your care at one of the specialist ALS centres taking part in France or Germany.

It's important that you are able to understand what the study involves and confirm you're happy to take part by signing a consent form. You should also be willing to take standard ALS medication, such as Riluzole, if prescribed by your doctor.

If you find it difficult to understand the study information, or if a medical condition prevents you from giving consent, you wouldn't be able to participate. This also applies if you are unwilling to take Riluzole therapy.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Sind Sie 18 Jahre alt oder älter?
  2. Have you been recently diagnosed with ALS?
  3. Are you receiving your ALS care at a specialist centre in France or Germany that is part of the study?
  4. Are you able to understand the study information and willing to sign a consent form?
  5. Are you willing to take standard ALS medication like Riluzole if prescribed?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

If you decide to take part in this study, you will receive the usual high-quality care for ALS patients from your specialist centre. In addition, for this study, you will be asked to complete several questionnaires. These questionnaires will help the researchers understand more about your health and experiences. You will also have blood samples taken. These blood samples will be analysed to look for specific 'biological markers' that might be linked to weight loss. The study does not involve taking any new medications, only standard care, questionnaires, and blood tests. The total duration of participation will depend on the study's follow-up schedule, but researchers will explain this fully during the consent process.

Potenzielle Risiken und Vorteile

Participating in this study might not directly benefit you, but it could help doctors understand weight loss in ALS better, leading to improved care for future patients. The main procedures involve blood collection, which carries a small risk of bruising or discomfort, and completing questionnaires. You are free to withdraw from the study at any time without giving a reason, and this will not affect the quality of your medical care.

Standorte (7)

  • CHU de Lille
    Verifizierte Postleitzahl
    Lille, Frankreich· Noch nicht rekrutiert
  • Limoges University Hospital
    Verifizierte Postleitzahl
    Limoges, Frankreich· Rekrutierung
  • Hôpital de la Timone
    Verifizierte Postleitzahl
    Marseille, Frankreich· Noch nicht rekrutiert
  • Hôpital Gui Chauliac
    Verifizierte Postleitzahl
    Montpellier, Frankreich· Noch nicht rekrutiert
  • CHU de Nice
    Verifizierte Postleitzahl
    Nizza, Frankreich· Noch nicht rekrutiert
  • Hôpital de la Pitié Salpêtrière
    Verifizierte Postleitzahl
    Paris, Frankreich· Noch nicht rekrutiert
  • CHU de Tours
    Verifizierte Postleitzahl
    Tours, Frankreich· Noch nicht rekrutiert

Häufige Fragen

What is ALS?

ALS, or Amyotrophic Lateral Sclerosis, is a condition that affects nerve cells in the brain and spinal cord, leading to muscle weakness over time.

Why is weight loss important in ALS?

Weight loss is common in ALS and can affect how people feel and their overall health. Understanding it better could lead to improved treatments.

Will I receive new medicine in this study?

No, this study does not involve new medicines. You will continue to receive your usual, standard medical care for ALS.

How much blood will be taken?

Blood samples will be taken for analysis, similar to a routine blood test you might have at your doctor's surgery.

What happens to my information?

All information collected, including blood samples and questionnaire responses, will be handled with strict confidentiality and used only for research purposes.

Wie Sie mehr erfahren können

Philippe COURATIER, Pr

philippe.couratier@chu-limoges.fr 05 55 05 15 69 Offizielles Gerichtsprotokoll

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "French-German Cohort Study to Determine Factors Associated W… wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.